Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 17/20 | 0.54 |
| ▸ | STS | P08842 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CCR4 | P51679 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5576089 | 1.00 | CCR5 (0.54) | CCR5STSTP53MAPTCCR4 | |
| SCHEMBL5572449 | 0.92 | CCR5 (0.47) | CCR5STSTP53MAPTCCR4 | |
| SCHEMBL4608051 | 0.92 | CCR5 (0.46) | CCR5STSTP53MAPTCCR4 | |
| SCHEMBL5572456 | 0.86 | STS (0.48) | CCR5STSTP53MAPT | |
| SCHEMBL4597857 | 0.86 | CCR5 (0.57) | CCR5CCR4KCNH2 | |
| SCHEMBL4625809 | 0.83 | STS (0.45) | STSTP53MAPT | |
| SCHEMBL4597776 | 0.82 | TP53 (0.47) | STSTP53MAPT | |
| SCHEMBL4595920 | 0.81 | STS (0.44) | CCR5STSTP53MAPT | |
| SCHEMBL5572558 | 0.81 | GPR119 (0.47) | CCR5TP53MAPT | |
| SCHEMBL5572556 | 0.81 | GPR119 (0.47) | CCR5TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070066624-A1 | Chemokine receptor binding compounds | ANORMED, INC. (CA) | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066624-A1 | Chemokine receptor binding compounds | CCR5, CCR4, CCR1 | CCR5 1/4885STS 4841/4885TP53 2854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.